- CVS Caremark to stop selling tobacco in all store locations
- CVS Caremark showcases outreach program to help customers understand health insurance options
- CVS Caremark to resume SilverScript enrollment Jan. 1
- MinuteClinic enters Northern California, Coastal Southeastern North Carolina
- CVS Caremark Q4 results rise to produce record year
CVS Caremark has announced the appointment of William Shrank as chief scientific officer and chief medical officer, provider innovation and analytics. In this role, Shrank will oversee the company’s overall research and clinical program development.
Why is this so important? Well, he’s a physician having previously practiced with Brigham Internal Medicine Associates. He also served as assistant professor at Harvard Medical School and served as director, research and rapid-cycle evaluation for the Center for Medicare & Medicaid Innovation at the Centers for Medicare & Medicaid Services. And what’s especially interesting to note — as highlighted by CVS Caremark — is that Shrank is “experienced in pharmaceutical outcomes research.”
This will be a critical position in the new age of health care where providers need to measure outcomes to get paid.
When referring to his new role at CVS Caremark, Shrank said he looks forward to expanding the company’s focus on medication adherence research and “uncovering new learnings to help our clients improve outcomes while managing cost."
CVS Caremark has aggressively positioned itself along the front lines of health care to help lower costs and improve patient outcomes. The appointment of Shrank is the latest example of that effort — and expect to see more.